 |
|
gemcitabine hydrochloride
The hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | difluorodeoxycytidine
gemcitabine | | | | US brand name: | | Gemzar | | | | Abbreviations: | | dFdC
dFdCyd | | | | Code name: | | LY-188011 | | | | Chemical structure names: | | - 1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose
- 2'-Deoxy-2',2'-difluorocytidine
- 2'Deoxy-2',2'-Difluorocytidine
| | |
|
|
